Interpace Biosciences, Inc. (IDXG)

OTCMKTS · Delayed Price · Currency is USD

1.068

+0.117 (12.37%)

At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Diagnostic Clinical Services	46.93M	Log In	Log In	Log In	Log In	Upgrade
Diagnostic Clinical Services Growth	16.69%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
United States	46.93M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	16.69%	Log In	Log In	Log In	Log In	Upgrade